Pathogenesis of Herpes Simplex Virus Infection and Animal Models for Its Study

  • L. R. Stanberry
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 179)


Overcoming infection with herpes simplex virus (HSV) depends upon a complex interaction between virus and host. This interaction most commonly produces asymptomatic infection, as illustrated by the high prevalence of HSV antibodies in individuals with no history of clinically recognized illness (Gibson et al. 1990; Johnson et al. 1989). These findings suggest that host responses are generally effective in limiting viral disease. Clearly this is not always the case since millions of individuals experience symptomatic HSV infections with disease ranging from trivial to life threatening (Whitley 1990). From epidemiological studies and clinical observations we have learned that both viral and host factors may influence whether an individual experiences an asymptomatic infection or is afflicted with severe herpetic disease. Clinical studies, however, are inherently limited and do not permit detailed exploration of the host and viral determinants of disease expression. The use of well-characterized experimental animal models has proven invaluable in further defining the natural history of HSV infection. With the recent advances in molecular biology and immunology, animal models are being increasingly used to investigate the role of selected viral genes and specific immune responses in the pathogenesis and immunobiology of HSV infection. This chapter will review the experimental animal models used to study HSV and summarize our current understanding of the pathogenesis of infection, with a primary focus on genital herpes. The immunobiology of HSV, as it pertains to viral pathogenesis and animal model research, will receive minimal attention in this chapter but will be presented in greater detail in other chapters in this volume.


Herpes Simplex Virus Herpes Simplex Virus Type Genital Herpes Recurrent Genital Herpes Herpes Simplex Virus Genome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson CA, August MJ, Hsiung GD (1980) Pathogenecity of wild-type and temperature sensitive mutants of herpes simplex virus type 2 in guinea pigs. Infect Immun 30:159–169PubMedGoogle Scholar
  2. Baron S, Worthington MG, Williams J, Gaines JW (1976) Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature 261: 505–506PubMedCrossRefGoogle Scholar
  3. Bernstein Dl, Stanberry LR (1986) Zosteriform spread of herpes simplex virus type 2 genital infection in the guinea-pig. J Gen Virol 67:1851–1857PubMedCrossRefGoogle Scholar
  4. Bernstein Dl, Stanberry LR, Harrison CJ, Kappes J, Myers MG (1986) Effects of oral acyclovir treatment of initial genital HSV-2 infection upon antibody response, recurrence patterns and subsequent HSV-2 reinfection in guinea pigs. J Gen Virol 67:1601–12PubMedCrossRefGoogle Scholar
  5. Bernstein Dl, Harrison CJ, Jenski LJ, Myers MG, Stanberry LR (1991) Cell mediated immunological responses and recurrent genital herpes in the guinea pig: effects of glycoprotein therapy. J Immunol 146:3571–3577PubMedGoogle Scholar
  6. Black WC (1942) The etiology of acute infectious gingivostomatitis. J Pedriatr 20:145–160CrossRefGoogle Scholar
  7. Blondeau JM, Aoki FY, Glavin GB, Nagy Jl (1991) Characterization of acute and latent herpes simplex virus infection of the dorsal root ganglia in rats. Lab Anim 25: 97–105PubMedCrossRefGoogle Scholar
  8. Blyth SNA, Hill TJ, Field HJ, Harbour DA (1976) Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostglandins. J Gen Virol 33: 547–550PubMedCrossRefGoogle Scholar
  9. Blyth WA, Harbour DA, Hill TJ (1984) Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. J Gen Virol 65:1477–1486PubMedCrossRefGoogle Scholar
  10. Bravo FJ, Myers MG, Bernstein Dl, Connelly BL, Harrison CJ, Kier AB, Stanberry LR (1990) Neonatal HSV infection in guinea pigs: a model to test antivirals. Abstracts of the 30th Intersci Conf Antimicrob Agents Chemother, Atlanta, abstract no 1104Google Scholar
  11. Brown ZA, Kern ER, Spruance SL, Overall JC Jr (1979) Clinical and virological course of herpes simplex genitalis. West J Med 130: 414–421PubMedGoogle Scholar
  12. Cai WH, Gu B, Person S (1988) Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol 62: 2596–2604PubMedGoogle Scholar
  13. Chou J, Kern ER, Whitley RJ, Roizman B (1990) Mapping of herpes simplex virus-1 neurovirulence to gamma 34.5, a gene nonessential for growth in culture. Science 250:1262–1266PubMedCrossRefGoogle Scholar
  14. Clements GB, Subak-Sharpe (1988) Herpes simplex virus type 2 establishes latency in the mouse footpad. J Gen Virol 69: 375–383PubMedCrossRefGoogle Scholar
  15. Cook ML, Stevens JG (1973) Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect Immun 7: 272–288PubMedGoogle Scholar
  16. Corey L, Spear PG (1986) Infections with herpes simplex viruses. N Engl J Med 314: 749–757PubMedCrossRefGoogle Scholar
  17. Corey L, Adams HG, Brown ZA, Holmes KK (1983) Genital herpes simplex virus infection: clinical manifestations, course and complications. Ann Intern Med 98: 958–972PubMedGoogle Scholar
  18. Croen KD, Ostrove JM, Dragovic L, Straus SE (1991) Characterization of herpes simlex virus type 2 latency associated transcription in human sacral ganglia and in cell culture. J Infect Dis 163: 23–28PubMedCrossRefGoogle Scholar
  19. Darai G, Schwaier A, Komitowski D, Munk K (1978) Experimental infection of Tupaia belanger (tree shrews) with herpes simplex virus types 1 and 2. J Infect Dis 137: 221–226PubMedCrossRefGoogle Scholar
  20. Desai PJ, Schaffer PA, Minson AC (1988) Excretion of non-infectious virus particles lacking glycoprotein H by a temperature sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J Gen Virol 69:1147–1156PubMedCrossRefGoogle Scholar
  21. Dix RD, McKendall RR, Baringer JR (1983) Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect infect 40: 103–112Google Scholar
  22. Donnenberg AD, Chaikof E, Aurelian L (1980) Immunity of herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs. Infect Immun 30: 99–109PubMedGoogle Scholar
  23. Field HJ (1988) Animal models in the evaluation of antiviral chemotherapy. In: Field HJ (ed) Antiviral agents: the development and assessment of antiviral chemotherapy, vol I. CRC Press, Boca Raton, pp 67–84Google Scholar
  24. Fraser-Smith EB, Smee DF, Matthews TR (1983) Efficacy of the acyclic nucleoside 9-(1,3-dihydoxy-2-propoxymethyl) guanine against primary and recrudescent genital herpes simplex virus type 2 infections in guinea pigs. Antimicrob Agents Chemother 24: 883–887PubMedGoogle Scholar
  25. Fuller AO, Spear PG (1987) Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus type 1 prevent virion-cell fusion at the cell surface. Proc. Natl Acad Sci USA 84: 5454–5458PubMedCrossRefGoogle Scholar
  26. Geller P, Coleman VR, Jawetz E (1953) Studies on herpes simplex virus: V. The fate of viable herpes simplex virus administered intravenously to man. J Immunol 71: 410–418PubMedGoogle Scholar
  27. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ (1990) A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 162: 306–312PubMedCrossRefGoogle Scholar
  28. Goodpasture EW, Teague O (1923) Transmission of the virus of herpes febrilis along nerves in experimentally infected rabbits. J Med Res 44:139–184PubMedGoogle Scholar
  29. Green MT, Rosborough JP, Dunkle EC (1981) In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model. Infect Immun 34: 69–76PubMedGoogle Scholar
  30. Harrison CJ, Myers MG (1990) Relation of maternal CMV viremia and antibody response to the rate of congenital infection and intrauterine growth retardation. J Med Virol 31: 222–228PubMedCrossRefGoogle Scholar
  31. Harrison CJ, Jenski L, Voychehovski T, Bernstein Dl (1988) Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection. Antiviral Res 10: 209–224PubMedCrossRefGoogle Scholar
  32. Hill TJ, Field HJ, Blyth WA (1975) Acute and recurrent infection with herpes simplex virus in the mouse-a model for studying latency and recurrent disease. J Gen Virol 28: 341–353PubMedCrossRefGoogle Scholar
  33. Ho RJY, Burke RL, Merigan TC (1989) Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs. J Virol 63: 2951–2958PubMedGoogle Scholar
  34. Hsiung GD, Chan VF (1989) Evaluation of new antiviral agents: II. The use of animal models. Antiviral Res 12: 239–258PubMedCrossRefGoogle Scholar
  35. Hsiung GD, Mayo DR, Lucia HL, Landry ML (1984) Genital herpes: pathogenesis and chemotherapy in the guinea pig model. Rev Infect Dis 6: 33–50PubMedCrossRefGoogle Scholar
  36. Javier RT, Sedafati F, Stevens JG (1986) Two avirulent herpes viruses interact in the animal to generate a virulent recombinant and a lethal infection. Science 234: 746–748PubMedCrossRefGoogle Scholar
  37. Javier RT, Izumi KM, Stevens JG (1988) Location of herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain. J Virol 62:1381–1387PubMedGoogle Scholar
  38. Johnson DC, Spear PG (1982) Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J Virol 43: 1102–1112PubMedGoogle Scholar
  39. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB (1989) A seroepidemiological survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 321:7–12PubMedCrossRefGoogle Scholar
  40. Kaner RJ, Baird A, Mansukhani A, Basilico C, Summers BD, Florkiewciz RZ, Hajjar DP (1990) Fibroblast growth factor receptor is the portal of cellular entry for herpes simplex virus type 1. Science 248:1410–1413PubMedCrossRefGoogle Scholar
  41. Katzin DS, Connor JD, Wilson LA, Sexton RS (1967) Experimental herpes simplex infection in the owl monkey. Proc Soc Exp Biol Med 125: 391–398PubMedGoogle Scholar
  42. Kern ER, Richards JT, Overall JC Jr, Glasgow LA (1978) Alteration of mortality and pathogenesis of three experimental herpesvirus hominis infections of mice with adenine arabinoside 5’-monophosphate, adenine arabinoside, and phosphonoacetic acid. Antimicrob Agents Chemother 13: 53–60PubMedGoogle Scholar
  43. Kern ER, Richards JT, Overall JC Jr (1986) Acyclovir treatment of disseminated herpes simplex virus type 2 infection of weanling mice: alteration of mortality and pathogenesis. Antiviral Res 6: 189–195PubMedCrossRefGoogle Scholar
  44. Klastersky J, Cappel R, Snocck JM, Flament J, Thiry L (1972) Ascending myelitis in association with herpes-simplex virus. N Engl J Med 287: 182–184PubMedCrossRefGoogle Scholar
  45. Klein J, DeStefano E (1983) Dissemination of herpes simplex virus in ganglia after footpad inoculation in neurectomized and non-neurectomized mice. Acta Virol 77: 231–238CrossRefGoogle Scholar
  46. Kristensson K, Lycke E, Sjostrand J (1971) Spread of herpes simplex in peripheral nerves. Acta Neuropathol (Berl) 17:44–53CrossRefGoogle Scholar
  47. Lopez C (1975) Genetics of natural resistance to herpesvirus infections in mice. Nature 258:152–153PubMedCrossRefGoogle Scholar
  48. Lycke E, Kristensson K, Svennerholm B, Vahine A, Ziegler R (1984) Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol 65: 55–64PubMedCrossRefGoogle Scholar
  49. Mani C, Stanberry LR, Bravo FJ, Bernstein Dl, Myers MG (1991) Neonatal herpes simplex virus infection in guinea pigs: effect of age on clinical disease and outcome (abstract) Pediatr Res 29:255AGoogle Scholar
  50. Meignier B, Longnecker R, Roizman B (1988) In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. J Infect Dis 158: 602–614PubMedCrossRefGoogle Scholar
  51. Meignier B, Martin B, Whitley J, Roizman B (1990) In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus). J Infect Dis 162: 313–321PubMedCrossRefGoogle Scholar
  52. Muller SA, Hermann FC, Winkelman RK (1972) Herpes simplex infections in hematological malignancies. Am J Med 52:102–114PubMedCrossRefGoogle Scholar
  53. Myers MG, Oxman MN, Clark JE, Arndt KA (1975) Failure of neutral-red photodynamic inactivation in recurrent herpes simplex infections. N Engl J Med 293: 945–949PubMedCrossRefGoogle Scholar
  54. Nahmias AJ, London WT, Catalona LW, Fuccillo DA, Sever JL, Graham C (1971) Genital herpesvirus hominis type 2 infection: an experimental model in Cebus monkeys. Science 171: 297–298PubMedCrossRefGoogle Scholar
  55. Nahmias AJ, Whitley RJ, Vistine AN, Takei Y, Alford CA Jr, the NIAID Collaborative Antiviral Study Group (1982) Herpes simplex encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis 145: 829–836PubMedCrossRefGoogle Scholar
  56. Nesburn AB, Cook ML, Stevens JG (1972) Latent herpes simplex virus: isolation from rabbit tri-gemmalganglia between episodes of recurrent ocular infection. Arch Ophthalmol 88: 412–417PubMedGoogle Scholar
  57. Overall JC Jr, Kern ER, Schlitzer RL, Friedman SB, Glasgow LA (1975) Genital herpesvirus hominis infection in mice. I. Development of an experimental model. Infect Immun 11: 476–480PubMedGoogle Scholar
  58. Perna JJ, Mannix ML, Rooney JF, Notkins AL, Straus SE (1987) Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model. J Am Acad Dermatol 17: 473–478PubMedCrossRefGoogle Scholar
  59. Polvino-Bodnar M, Orberg PK, Schaffer PA (1987) Herpes simplex virus type 1 oriL is not required for virus replication or for the establishment and reactivation of latent infection in mice. J Virol 61:3528–3535PubMedGoogle Scholar
  60. Rector JT, Lausch RN, Oakes JE (1982) Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infect Immun 38: 168–174PubMedGoogle Scholar
  61. Reeves WC, DiGiacomo RF, Alexander ER, Lee CK (1976) Latent herpesvirus hominis from the trigeminal and sacral dorsal root ganglia of Cebus monkeys. Proc Soc Exp Biol Med 153: 258–261PubMedGoogle Scholar
  62. Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK (1981) Risk of recurrence after episodes of genital herpes: relation of HSV type and antibody response. N Engl J Med 305: 315–319PubMedCrossRefGoogle Scholar
  63. Renis HE (1975) Genital infection of female hamsters with herpesvirus hominis type 2 (HVH-2). Proc Soc Exp Biol Med 150: 723–727PubMedGoogle Scholar
  64. Roizman B, Sears AE (1990) Herpes simplex viruses and their replication. In: Field BN, Knipe DM (eds) Virology. Raven, New York, pp 1795–1841Google Scholar
  65. Rosenthal KS, Roess D, Barisas BG (1988) Herpes simplex virus type 1 initiates mobilization of cell surface proteins. Biochim Biophys Acta 942: 38–44PubMedCrossRefGoogle Scholar
  66. Rosen-Wolff A, Scholz J, Darai G (1989) Organotropism of latent herpes simplex virus type 1 is correlated to the presence of a 1.5 kb RNA transcript mapped within the BamHI DNA fragment B (0.738 to 0.809 map units). Virus Res 12: 43–52PubMedCrossRefGoogle Scholar
  67. Rouse BT, Norley S, Martin S (1988) Antiviral cytotoxic T lymphocyte induction and vaccination. Rev Infect Dis 10:16–33PubMedCrossRefGoogle Scholar
  68. Schwartz J, Roizman B (1969) Similarities and differences in the development of laboratory strains of herpes simplex virus in HEp-2 cells: electron microscopy. J Virol 4: 879–889PubMedGoogle Scholar
  69. Scriba M, Tatzber F (1981) Pathogenesis of herpes simplex virus infections in guinea pigs. Infect Immun 34: 655–661PubMedGoogle Scholar
  70. Sedarti F, Izumi KM, Wagner EK, Stevens JG (1989) Herpes simplex virus type 1 latency-associated transcription plays no role in the establishment or maintenance of a latent infection in murine sensory neurons. J Virol 63: 4455–4458Google Scholar
  71. Simmons A, Nash AA (1987) Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J Infect Dis 155: 469–475CrossRefGoogle Scholar
  72. Smolin G, Okumoto MA, Ohno S (1976) Experimental herpetic keratitis in the guinea pig. Surv Ophthalmol 21:205–208PubMedCrossRefGoogle Scholar
  73. Spivack JG, Fräser NW (1987) Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J Virol 61: 3841–3847PubMedGoogle Scholar
  74. Spruance SL, McKeough MB (1988) Evaluation of antiviral treatments for recurrent herpes simplex labialis in the dorsal cutaneous guinea pig model. Antiviral Res 9: 295–313PubMedCrossRefGoogle Scholar
  75. Stanberry LR (1986) Herpesvirus latency and recurrence. Prog Med Virol 33: 61–77PubMedGoogle Scholar
  76. Stanberry LR (1989) Animal model of ultraviolet-radiation-induced recurrent herpes simplex virus infection. J Med Virol 28:125–128PubMedCrossRefGoogle Scholar
  77. Stanberry LR (1990a) Capsaicin interfers with the centrifugal spread of virus in primary and recurrent genital herpes simplex virus infection. J Infect Dis 162: 29–34PubMedCrossRefGoogle Scholar
  78. Stanberry LR (1990b) Subunit viral vaccines: therapeutic and prophylactic uses. In: Aurelian L (ed) Herpesviruses, the immune systems and aids. Kluwer, Boston, pp 309–341CrossRefGoogle Scholar
  79. Stanberry LR (1991) Herpes simplex virus vaccines. Semin Pediatr Infect Dis 2(3): 178–185Google Scholar
  80. Stanberry LR, Kern ER, Richards JT, Abbott TM, Overall JC Jr (1982) Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis 146: 397–404PubMedCrossRefGoogle Scholar
  81. Stanberry LR, Kit S, Myers MG (1985a) Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J Virol 55: 322–328PubMedGoogle Scholar
  82. Stanberry LR, Kern ER, Richards JT, Overall JC Jr (1985b) Recurrent genital herpes simplex virus infection in the guinea pig. Intervirology 24: 226–231PubMedCrossRefGoogle Scholar
  83. Stanberry LR, Bernstein Dl, Burke RL, Pachl C, Myers MG (1987) Recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis 155: 914–920PubMedCrossRefGoogle Scholar
  84. Stanberry LR, Burke RL, Myers MG (1988) Herpes simplex virus glycoprotein treatment of recurrent genital herpes. J Infect Dis 157:156–163PubMedCrossRefGoogle Scholar
  85. Stanberry LR, Harrison CJ, Bernstein Dl, Burke RL, Shukla R, Ott G, Myers MG (1989) Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: factors influencing efficacy. Antiviral Res 11: 203–214PubMedCrossRefGoogle Scholar
  86. Stephanopoulos DE, Myers MG, Bernstein Dl (1989) Genital infections due to herpes simplex virus type 2 in male guinea pigs. J Infect Dis 159: 89–95PubMedCrossRefGoogle Scholar
  87. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT (1987) RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235:1056–1059PubMedCrossRefGoogle Scholar
  88. Stroop WG, Schaefer DC (1986) Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus. Invest Opthalmol Vis Sci 28: 229–237Google Scholar
  89. Stulting RD, Kindle JC, Nahmias A (1985) Patterns of herpetic keratitis in inbred mice. Invest Ophthalmol Vis Sci 26:1360–1367PubMedGoogle Scholar
  90. Tenser RB, Hsiung GD (1977) Pathogenesis of latent herpes simplex virus infection of the trigeminal ganglion in guinea pigs: effects of age, passive immunization, and hydrocortisone. Infect Immun 16: 69–74PubMedGoogle Scholar
  91. Thompson RL, Rogers SK, Zerhusen MA (1989) Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0.82 and 0.832 map units on the HSV genome. Virology 172: 435–450PubMedCrossRefGoogle Scholar
  92. Von Hoff DD, Luckey M, Wallace J (1975) Herpes simplex virus type 2 meninigitis following herpes progenitalis. West J Med 123: 490–491Google Scholar
  93. Walz MA, Price RW, Hayashi K, Katz BJ, Notkins AL (1977) Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex viruses types 1 and 2. J Infect Dis 135:744–752PubMedCrossRefGoogle Scholar
  94. Wander AH, Bubel HC, McDowell SG (1987) The pathogenesis of herpetic ocular disease in the guinea pig. Arch. Arch Virol 95: 197–209CrossRefGoogle Scholar
  95. Wheeler CE Jr (1975) Pathogenesis of recurrent herpes simplex infections. J Invest Dermatol 65: 341–346PubMedCrossRefGoogle Scholar
  96. Whitley RJ (1990) Herpes simplex viruses. In: Fields BN, Knipe DM (eds) Virology. Raven, New York, pp 1843–1887Google Scholar
  97. Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, Starr S, Jacobs R, Powell D, Nahmias A, Sumaya C, Edwards K, Alford C, Caddell G, Soong S-J (1991) Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 324: 450–454PubMedCrossRefGoogle Scholar
  98. Whittum JA, McCulley JP, Niederkorn JY, Streilein JW (1984) Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest Ophthalmol Vis Sci 25:1065–1971PubMedGoogle Scholar
  99. WuDunn D, Spear PG (1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 63: 52–58PubMedGoogle Scholar
  100. Yen SSC, Reagan JW, Rosenthal MS (1965) Herpes simplex infection in the female genital tract. Obstet Gynecol 25: 479–492PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin, Heidelberg 1992

Authors and Affiliations

  • L. R. Stanberry
    • 1
  1. 1.Division of Infectious Diseases, Children’s Hospital Research FoundationUniversity of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations